Recent Company News

• 10:19 AM ET Aug 23, 2025
  

  Stifel re-initiates ABVX.FP, BINV.SS, CAMX.SS, others

• 09:15 PM ET Aug 22, 2025
  

  FDA has suspended the BLA for Valneva's IXCHIQ; cites CBER's benefit-risk analysis ($11.64, 0.00)

• 02:50 PM ET Aug 22, 2025
  

  Valneva halted for news ($11.64, +0.45)

• 10:06 AM ET Aug 19, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (74 total)

• 06:21 AM ET Aug 19, 2025
  

  HC Wainwright assumes GNFT, VALN

• 06:56 AM ET Aug 18, 2025
  

  Healthcare, utilities and retail higher; energy, banks and construction/materials biggest laggard:

• 04:03 AM ET Aug 18, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 04:02 AM ET Aug 18, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (77 total)

• 02:54 AM ET Aug 18, 2025
  

  StreetAccount Summary - European pre-market trading update

• 01:01 AM ET Aug 18, 2025
  

  Valneva's Chikungunya Vaccine IXCHIQ Now Authorized in Canada for Individuals Aged 12 and Older (€4.78, 0.00)